北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学药学院  > 药剂学系  > 期刊论文
学科主题: 药学
题名:
RGD-based strategies for improving antitumor activity of paclitaxel-loaded liposomes in nude mice xenografted with human ovarian cancer
作者: Zhao, Hui1,2; Wang, Jian-Cheng1; Sun, Qi-Shi2; Luo, Chun-Lei1; Zhang, Qiang1,3
关键词: RGD peptide ; targeting liposomes ; paclitaxel ; antitumor
刊名: JOURNAL OF DRUG TARGETING
发表日期: 2009
DOI: 10.1080/10611860802368966
卷: 17, 期:1, 页:10-18
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Pharmacology & Pharmacy
研究领域[WOS]: Pharmacology & Pharmacy
关键词[WOS]: STERICALLY STABILIZED LIPOSOMES ; TAXOL-CONTAINING LIPOSOMES ; IN-VIVO ; INTRACELLULAR DELIVERY ; CELL-ADHESION ; DOXORUBICIN ; INTEGRINS ; EFFICACY ; FORMULATIONS ; THERAPY
英文摘要:

Tumor-targeting drug delivery systems are being the ideal carrier for systemic administration of antiproliferative drugs. RGD peptide (arginine-glycine-aspartic acid) modified liposomes containing paclitaxel (RGD-SSL-PTX). The arginine-glycineaspartic acid tripeptide (RGD) modified sterically stabilized liposomes (SSL) containing paclitaxel (PTX) (RGD-SSL-PTX), which could increase targeting to tumor by binding with the integrin receptors overexpressed on tumor cells. The encapsulation efficiency was more than 90% and the mean particle size was of 120nm with a narrow size distribution. It was indicated that significant cytotoxicity (3.5 times lower IC(50)) was found in the SKOV-3 human ovarian cancer cells treated with RGD-SSL-PTX preparation, as well as the intracellular uptake of liposomes (a 6.21-fold increase in fluorescence intensity), when compared to those of non-targeted liposomes (SSL). For in vivo antitumor activity, it was shown in the present study thatRGD-SSL-PTX preparation had the strongest tumor growth inhibition among the test formulations (P < 0.05) in BALB/c nude mice xenografted with SKOV-3 solid tumor. Meanwhile, there was no significant change in the body weight of the animals treated with RGD-SSL-PTX for intravenous injection at a dose of 12.5 mg/kg. It was suggested that the RGD-SSL-PTX preparation might have a great advantage over present-day chemotherapy with Taxol (R) in curing those tumors overexpressing integrin receptors.

语种: 英语
所属项目编号: 30430760 ; 30572261 ; 2007CB935801
项目资助者: National Natural Science Foundation of China ; National Basic Research Program of China (973 program)
WOS记录号: WOS:000261943900002
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/57230
Appears in Collections:北京大学药学院_药剂学系_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Peking Univ, Sch Pharmaceut Sci, Dept Pharmaceut, Beijing 100083, Peoples R China
2.Shenyang Pharmaceut Univ, Dept Tradit Chinese Med, Shenyang 110015, Peoples R China
3.Peking Univ, State Key Lab Nat & Biomimet Drugs, Beijing 100083, Peoples R China

Recommended Citation:
Zhao, Hui,Wang, Jian-Cheng,Sun, Qi-Shi,et al. RGD-based strategies for improving antitumor activity of paclitaxel-loaded liposomes in nude mice xenografted with human ovarian cancer[J]. JOURNAL OF DRUG TARGETING,2009,17(1):10-18.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Zhao, Hui]'s Articles
[Wang, Jian-Cheng]'s Articles
[Sun, Qi-Shi]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Zhao, Hui]‘s Articles
[Wang, Jian-Cheng]‘s Articles
[Sun, Qi-Shi]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace